Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selec
Description
Small Molecule Drug Discovery Market, By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification, and Lead Optimization), and By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Small molecule drugs have represented some of the crucial blockbusters in the history of the pharmaceutical industry. Defined as any organic compound with low molecular weight, small molecule drugs have some distinct advantages as therapeutics. Small molecule drugs capable of modulating biochemical processes to diagnose, treat, and prevent diseases. Small molecule drugs are the mainstay of medicine, representing around 90 percent of all approved medicines and 75 percent of all new medicines approved in the U.S. in 2020.
Market Dynamics:
High prevalence of chronic diseases, increase in demand for small molecule drugs, rise in focus on small molecule drug discovery, increasing number of contract organizations, and increase in research and development activities are some major factors expected to augment the growth of the global small molecule drug discovery market.
In July 2022, RxCelerate revealed details of a new small molecule discovery platform, named RxNfinity, which leverages machine learning, in silico structure modeling and combinatorial chemistry in a novel workflow that offers significant advantages over the current generation of tools to identify small molecule drugs against a wide range of protein targets.
In July 2022, Dotmatics announced the release of its Small Molecule Drug Discovery Solution, an integrated scientific research and development platform with pre-configured workflows and expanded data management capabilities. The new solution will help companies innovate more easily by leveraging best practices derived from Dotmatics’ 15+ years of experience supporting small molecule drug discovery.
Key features of the study:
Small molecule drugs have represented some of the crucial blockbusters in the history of the pharmaceutical industry. Defined as any organic compound with low molecular weight, small molecule drugs have some distinct advantages as therapeutics. Small molecule drugs capable of modulating biochemical processes to diagnose, treat, and prevent diseases. Small molecule drugs are the mainstay of medicine, representing around 90 percent of all approved medicines and 75 percent of all new medicines approved in the U.S. in 2020.
Market Dynamics:
High prevalence of chronic diseases, increase in demand for small molecule drugs, rise in focus on small molecule drug discovery, increasing number of contract organizations, and increase in research and development activities are some major factors expected to augment the growth of the global small molecule drug discovery market.
In July 2022, RxCelerate revealed details of a new small molecule discovery platform, named RxNfinity, which leverages machine learning, in silico structure modeling and combinatorial chemistry in a novel workflow that offers significant advantages over the current generation of tools to identify small molecule drugs against a wide range of protein targets.
In July 2022, Dotmatics announced the release of its Small Molecule Drug Discovery Solution, an integrated scientific research and development platform with pre-configured workflows and expanded data management capabilities. The new solution will help companies innovate more easily by leveraging best practices derived from Dotmatics’ 15+ years of experience supporting small molecule drug discovery.
Key features of the study:
- This report provides in-depth analysis of the global small molecule drug discovery market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global small molecule drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Teva Pharmaceuticals, Merck KgaA, Johnson & Johnson, GlaxoSmithKline PLC, Gilead Sciences Inc., AstraZeneca, Immunocure Inc., Acacia Pharma Gr, 4SC AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, 21st Century Therapeutics, Novartis, Pfizer Inc., and Takeda Pharmaceutical Industries Ltd., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global small molecule drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule drug discovery market.
- Global Small Molecule Drug Discovery Market, By Therapeutic Area:
- Oncology
- Central Nervous System
- Cardiovascular
- Respiratory
- Metabolic Disorders
- Gastrointestinal
- Other Therapeutic Areas
- Global Small Molecule Drug Discovery Market, By Process/Phase:
- Target ID/Validation
- Hit Generation and Selection
- Lead Identification
- Lead Optimization
- Global Small Molecule Drug Discovery Market, By Geography:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Company Profiles:
- Teva Pharmaceuticals
- Merck KgaA
- Johnson & Johnson
- GlaxoSmithKline PLC
- Gilead Sciences Inc.
- AstraZeneca
- Immunocure Inc.
- Acacia Pharma Gr
- 4SC AG
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- 21st Century Therapeutics Inc.
- Novartis
- Pfizer Inc.
- Takeda Pharmaceutical Industries Ltd.
Table of Contents
165 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Test Type
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Reimbursement Scenario
- PEST Analysis
- Industry Trend
- New Product Approvals/Launch
- Merger and Acquisitions
- Technological Advancement
- 4. Global Metabolic Testing Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- COVID-19 Impact on the market
- 5. Global Metabolic Testing Market, By Product Type, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Metabolic Carts
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Portable
- Bench-top
- Body Composition Analyzers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Portable
- Bench-top
- ECGs/EKGs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Portable
- Bench-top
- 6. Global Metabolic Testing Market, By Test Type, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- VO2 Max Analysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- RMR Analysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Body Composition Analysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- 7. Global Metabolic Testing Market, By End User,2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017– 2030
- Segment Trends
- Hospitals and Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Sports Performance Lab
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Home Care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- 8. Global Metabolic Testing Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million )
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million )
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million )
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million )
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million )
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By End user, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million )
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- Heat Map Analysis
- Company Profile
- COSMED srl
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Vyaire Medical, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Geratherm Medical AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- MGC Diagnostics Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- CORTEX Biophysik GmbH
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- General Electric Company
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Microlife Medical Home Solutions, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- OSI Systems, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- AEI Technologies, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- KORR Medical Technologies, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Iworx Systems
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Hologic, Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Geratherm Medical AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Parvo Medics
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
- 10. Section
- References
- Research Methodology
- About Us
- *Browse 35 market data tables and 34 figures on “Global Metabolic Testing Market” -Global forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
